Tag: OSX
Osteopore signs first US distribution deal for 3D-printed craniofacial scaffolds
Bone healing biotech company Osteopore (ASX: OSX) has secured an agreement with American cranial bone fixation specialist Bioplate Inc to promote and sell Osteopore products into the US market.
It ...
Securing best distributor is key to commercialisation in the medical field
A company can create a product that has the ability to change the world, but its commercial success and failure often hinges on how the product enters the market – particularly for complex products li...
COVID-19 prompts increased shift towards 3D printed medical material
With 3D printed material becoming increasingly common in the medical field, the onset of COVID-19 has sparked even further demand for materials made in this revolutionary fashion.
Low supplies and ...
Osteopore receives TGA approval for 3D-printed medical scaffolds in Australia
Osteopore (ASX: OSX) is now be able to make its 3D-printed medical scaffolds widely available across Australia after its three craniofacial products were approved by the Therapeutic Goods Administrati...
Osteopore continues sales momentum despite COVID-19 climate
Biotech company Osteopore (ASX: OSX) is continuing to see strong sales of its 3D-printed ‘bone healing’ implants as its Singaporean manufacturing facility remains fully operational amid COVID-19 conta...
Osteopore boosts revenue, plans to break into Chinese and US markets
Bone healing biotech company Osteopore (ASX: OSX) has posted strong revenue growth since its ASX debut, eyeing China and the US as the next markets for its regenerative technology.
The Austra...
Osteopore makes ASX debut, plans to become leading producer of 3D-printed implants to promote bone regeneration
Medical technology company Osteopore (ASX: OSX) has made its ASX debut with a $20.2 million market capitalisation following a successful initial public offering which closed early due to strong invest...
